Sindromul de intestin iritabil și locul probioticelor în strategiile terapeutice. (Romanian)

Irritable bowel syndrome and probiotics place in therapeutic strategies. (English)

Irritable bowel syndrome is a frequent digestive condition, with an unclear etiopathogeny. Very probably intestinal dysbiosis plays an important role. For the moment there are no guidelines for treatment. There is scientific evidence for several therapies: modification of diet, non-resorbable antibiotics (rifaximin-α) and probiotics. Giving probiotics after each antibiotic course (an association of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001) supplemented with vitamin B6 may be an optimal strategy. [ABSTRACT FROM AUTHOR]

Sindromul de intestin iritabil este o afecțiune digestivă frecvent intalnită, cu etiopatogenie incomplet ințeleasă, in care disbioza intestinală joacă probabil un rol important. Nu există in prezent un tratament standardizat. Principiile de tratament pentru care există dovezi științifice sunt: modificarea dietei, tratamentul cu antibiotice neresorbabile (rifaximină-α) și administrarea de probiotice. Administrarea după fiecare cură de antibiotic a unei asocieri de probiotice (Bifidobacterium longum BB536 și Lactobacillus rhamnosus HN001) suplimentată cu vitamina B6 poate fi o variantă optimă de tratament. [ABSTRACT FROM AUTHOR]

Copyright of Infectio.ro is the property of MEDICHUB MEDIA, S.R.L. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)